Signaturefd, LLC Biogen Inc. Transaction History

Signaturefd, LLC

$5.8 Billion
Q3 2025

A detailed history of Signaturefd, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 4,342 shares of BIIB stock, worth $727,502. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,342

Previous 4,571 5.01%

Holding current value

$727,502

Previous $574,000 5.92%

% of portfolio

0.01%

Previous 0.01%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 21, 2025	SELL	$122.68 - $148.84 $28,093 - $34,084	-229 Reduced 5.01%	4,342 $608,000
Q2 2025 Jul 16, 2025	BUY	$113.38 - $135.49 $212,474 - $253,908	1,874 Added 69.48%	4,571 $574,000
Q1 2025 May 01, 2025	BUY	$133.43 - $153.27 $80,725 - $92,728	605 Added 28.92%	2,697 $369,000
Q4 2024 Feb 10, 2025	BUY	$146.47 - $191.55 $10,399 - $13,600	71 Added 3.51%	2,092 $319,000
Q3 2024 Oct 21, 2024	SELL	$189.07 - $236.8 $241,442 - $302,393	-1,277 Reduced 38.72%	2,021 $391,000
Q2 2024 Jul 29, 2024	BUY	$190.52 - $236.72 $249,581 - $310,103	1,310 Added 65.9%	3,298 $764,000
Q1 2024 May 03, 2024	SELL	$212.02 - $267.71 $38,375 - $48,455	-181 Reduced 8.34%	1,988 $428,000
Q4 2023 Jan 31, 2024	SELL	$222.59 - $267.94 $8,235 - $9,913	-37 Reduced 1.68%	2,169 $561,000
Q3 2023 Nov 03, 2023	SELL	$253.3 - $285.89 $88,401 - $99,775	-349 Reduced 13.66%	2,206 $566,000
Q2 2023 Aug 01, 2023	BUY	$275.25 - $318.06 $44,590 - $51,525	162 Added 6.77%	2,555 $727,000
Q1 2023 Apr 28, 2023	SELL	$256.56 - $292.34 $18,728 - $21,340	-73 Reduced 2.96%	2,393 $665,000
Q4 2022 Jan 27, 2023	BUY	$252.44 - $306.72 $185,038 - $224,825	733 Added 42.3%	2,466 $682,000
Q3 2022 Nov 08, 2022	SELL	$194.69 - $268.46 $16,353 - $22,550	-84 Reduced 4.62%	1,733 $463,000
Q2 2022 Aug 10, 2022	SELL	$187.54 - $223.02 $12,002 - $14,273	-64 Reduced 3.4%	1,817 $371,000
Q1 2022 May 02, 2022	SELL	$193.77 - $244.14 $58,906 - $74,218	-304 Reduced 13.91%	1,881 $396,000
Q4 2021 Jan 25, 2022	SELL	$223.92 - $287.77 $66,952 - $86,043	-299 Reduced 12.04%	2,185 $524,000
Q3 2021 Oct 28, 2021	BUY	$282.99 - $369.05 $22,356 - $29,154	79 Added 3.28%	2,484 $703,000
Q2 2021 Jul 26, 2021	BUY	$259.0 - $414.71 $66,304 - $106,165	256 Added 11.91%	2,405 $833,000
Q1 2021 Apr 30, 2021	BUY	$242.95 - $284.63 $8,989 - $10,531	37 Added 1.75%	2,149 $601,000
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $346,120 - $520,997	-1,465 Reduced 40.96%	2,112 $517,000
Q3 2020 Nov 03, 2020	BUY	$264.77 - $305.71 $245,706 - $283,698	928 Added 35.03%	3,577 $1.02 Million
Q2 2020 Jul 30, 2020	SELL	$258.66 - $342.55 $25,866 - $34,255	-100 Reduced 3.64%	2,649 $709,000
Q1 2020 Apr 23, 2020	BUY	$268.85 - $341.04 $123,402 - $156,537	459 Added 20.04%	2,749 $870,000
Q4 2019 Feb 05, 2020	SELL	$220.06 - $304.07 $39,390 - $54,428	-179 Reduced 7.25%	2,290 $680,000
Q3 2019 Oct 16, 2019	BUY	$217.44 - $243.88 $154,817 - $173,642	712 Added 40.52%	2,469 $575,000
Q2 2019 Jul 31, 2019	SELL	$219.29 - $241.72 $77,847 - $85,810	-355 Reduced 16.81%	1,757 $411,000
Q1 2019 May 09, 2019	SELL	$216.71 - $338.96 $26,438 - $41,353	-122 Reduced 5.46%	2,112 $499,000
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $50,130 - $63,495	180 Added 8.76%	2,234 $672,000
Q3 2018 Nov 15, 2018	BUY	$293.51 - $383.83 $23,774 - $31,090	81 Added 4.11%	2,054 $726,000
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $122,579 - $146,089	476 Added 31.8%	1,973 $573,000
Q1 2018 May 08, 2018	BUY	$260.13 - $367.91 $22,371 - $31,640	86 Added 6.09%	1,497 $410,000
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $31,379 - $35,147	102 Added 7.79%	1,411 $450,000
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $55,948 - $65,608	199 Added 17.93%	1,309 $410,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,110	1,110 $301,000

Others Institutions Holding BIIB

# of Institutions

1,070

Shares Held

128M

Call Options Held

3.03M

Put Options Held

2.24M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $24.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account